# A Trial of KB004 in Patients With Glioblastoma

> **NCT03374943** · PHASE1 · COMPLETED · sponsor: **Olivia Newton-John Cancer Research Institute** · enrollment: 12 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** KB004

## Key facts

- **NCT ID:** NCT03374943
- **Lead sponsor:** Olivia Newton-John Cancer Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-05
- **Primary completion:** 2021-01-25
- **Final completion:** 2021-09-22
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03374943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03374943, "A Trial of KB004 in Patients With Glioblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03374943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*